BackChugai Pharmaceutical , Ltd. Overview

Chugai Pharmaceutical , Ltd. Accounts Payable

Latest accounts payable for CHGCF: $78B.

Get informed when a big investor buys or sells

+ Follow
Accounts Payable
$78.17B
↓ 2.31% YoYΔ $-1.85B vs prior year quarter

Peer trimmed avg / median

Loading

Chugai Pharmaceutical , Ltd. Accounts Payable History

Loading

Chugai Pharmaceutical , Ltd. vs. peers: Accounts Payable Comparison

Loading

Chugai Pharmaceutical , Ltd. Accounts Payable Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Chugai Pharmaceutical , Ltd. (CHGCF) FAQ

The latest accounts payable for CHGCF is $78B as of September 2026. That compares with $80B in the prior-year period — down 2.3% year over year. Investors often review this figure alongside Chugai Pharmaceutical , Ltd.'s historical trend and sector peers before judging valuation or financial health.

Over the past year, CHGCF's accounts payable moved from $80B to $78B — a 2.3% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Chugai Pharmaceutical , Ltd.'s operating scale or balance-sheet position.

A accounts payable figure of $78B for CHGCF is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting CHGCF's accounts payable ($78B), review year-over-year change from $80B, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.